Another drug for treatment of COVID-19 patients soon to be launched in India
Bhubaneswar: In what could be a positive sign in the fight against COVID-19, leading multinational pharmaceutical company Cipla will soon come up with Favipiravir, an off-patent anti-viral drug, developed by Council of Scientific and…